Effect of co-injection of arachydonilcyclopropylamide and ethanol on conditioned place preference in rats

Physiology and Behavior

Volumn 107, Issue 3, 2012, Pages 301-308

  Rezayof, Ameneh ^a   Ghandipour, Mahdieh ^a   Nazari Serenjeh, Farzaneh ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

ACPA; Brain sites; Conditioned place preference; Ethanol; Rat(s)

Indexed keywords

ALCOHOL; ARACHIDONYLCYCLOPROPYLAMIDE; CANNABINOID 1 RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; BASOLATERAL AMYGDALA; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

EID: 84867132463     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.08.009     Document Type: Article

References (77)

1. Pietrzak B, Dunaj A, Piatkowska K. The role of the cannabinoid system in the pathogenesis and treatment of ethanol dependence. Postepy Hig Med Dosw (Online) 2011;65:606-15.
2. Economidou D, Mattioli L, Ubaldi M, Lourdusamy A, Soverchia L, Hardiman G, et al. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol. Toxicol Appl Pharmacol 2007;223:73-85.
3. Maccioni P, Colombo G, Carai MA. Blockade of the cannabinoid CB1 receptor and ethanol dependence: preclinical evidence and preliminary clinical data. CNS Neurol Disord Drug Targets 2010;9:55-9.
4. Economidou D,Mattioli L, Cifani C, Perfumi M,Massi M, Cuomo V, et al. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology (Berl) 2006;183: 394-403.
5. Cippitelli A, Bilbao A, Gorriti MA, Navarro M, Massi M, Piomelli D, Ciccocioppo R, Rodriguez de Fonseca F. The anandamide transport inhibitor AM404 reduces ethanol self-administration. Eur J Neurosci 2007;26:476-86.
6. Ferrer B, Bermudez-Silva FJ, Bilbao A, Alvarez-Jaimes L, Sanchez-Veral, Giuffrida A, et al. Regulation of brain anandamide by acute administration of ethanol. Biochem J 2007;15:97-104.
7. Gessa GL, Serra S, Vacca G, Carai MA, Colombo G. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. Alcohol Alcohol 2005;40:46-53.
8. Mechoulam R, Parker L. Cannabis and ethanol-a close friendship. Trends Pharmacol Sci 2003;24:266-8.
9. Lupica CR, Riegel AC. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 2005;48:1105-16.
10. Hungund BL, Szakall I,AdamA, Basavarajappa BS, Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary ethanol consumption and lack ethanol-induced dopamine release in the nucleus accumbens. J Neurochem 2003;84:698-704.
11. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004;47(Suppl. 1):345-58.
12. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 2005;168:299-325.
13. Gonzalez S, Valenti M, de Miguel R, Fezza F, Fernandez-Ruiz J, Di Marzo V, et al. Changes in endocannabinoid contents in reward-related brain regions of ethanol-exposed rats, and their possible relevance to ethanol relapse. Br J Pharmacol 2004;143:455-64.
14. Malinen H, Lehtonen M, Hyytia P. Modulation of brain endocannabinoid levels by voluntary ethanol consumption in ethanol-preferring AA rats. Alcohol Clin Exp Res 2009;33:1711-20.
15. Ortiz S, Oliva JM, Perez-Rial S, Palomo T,Manzanares J. Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. Alcohol Alcohol 2004;39:88-92.
16. Hungund BL, Basavarajappa BS. Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence. Alcohol Alcohol 2000;35:126-33.
17. Ramaekers JG, Theunissen EL, de Brouwer M, Toennes SW, Moeller MR, Kauert G. Tolerance and cross-tolerance to neurocognitive effects of THC and ethanol in heavy cannabis users. Psychopharmacology (Berl) 2011;214:391-401.
18. Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND. Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 2005;164:206-13.
19. Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007;12:227-462.
20. Ferbinteanu J, McDonald RJ. Dorsal/ventral hippocampus, fornix, and conditioned place preference. Hippocampus 2001;11:187-200.
21. Bechtholt AJ, Cunningham CL. Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism. Behav Neurosci 2005;119:213-23.
22. Rogers JL, See RE. Selective inactivation of the ventral hippocampus attenuates cue-induced and cocaine-primed reinstatement of drug-seeking in rats. Neurobiol Learn Mem 2007;87:688-92.
23. Zangen A, Solinas M, Ikemoto S, Goldberg SR, Wise RA. Two brain sites for cannabinoid reward. J Neurosci 2006;26:4901-7.
24. Zarrindast MR, Meshkani J, Rezayof A, Beigzadeh R, Rostami P. Nicotinic acetylcholine receptors of the dorsal hippocampus and the basolateral amygdala areinvolved in ethanol-induced conditioned place preference. Neuroscience 2010;168:505-13.
25. Wise RA. Drug-activation of brain reward pathways. Drug Alcohol Depend 1998;51:13-22.
26. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991;11:563-83.
27. Thomas BF, Wei X, Martin BR. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH. J Pharmacol Exp Ther 1992;263:1383-90.
28. Perez-Reyes M, Hicks RE, Bumberry J, Jeffcoat AR, Cook CE. Interaction between marihuana and ethanol: effects on psychomotor performance. Alcohol Clin Exp Res 1988;12:268-76.
29. Ballard ME, de Wit H. Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers. Pharmacol Biochem Behav 2011;97(4):627-31.
30. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press; 2007.
31. Carr GD, White NM. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci 1983;33:2551-7.
32. De Fonseca FRD, Rubio P, Martin-Caldon JL, Caine SB, Koob GF, Navarro M. The dopamine receptor agonist 7-OH-DPATmodulates the acquisition and expression of morphine-induced place preference. Eur J Pharmacol 1995;274:47-55.
33. Bienkowski P, Kuca P, Piasecki J, Kostowski W. Low dose of ethanol induces conditioned place preference in rats after repeated exposures to ethanol or saline injections. Alcohol Alcohol 1996;31:547-53.
34. Blatt SL, Takahashi RN. Experimental anxiety and the reinforcing effects of ethanol in rats. Braz J Med Biol Res 1999;32:457-61.
35. Cole JC, Sumnall HR, O'Shea E, Marsden CA. Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology (Berl) 2003;166:383-90.
36. Quertemont E, De Witte P. Conditioned stimulus preference after acetaldehyde but not ethanol injections. Pharmacol Biochem Behav 2001;68:449-54.
37. Bozarth MA. Evidence for the rewarding effects of ethanol using the conditioned place preference method. Pharmacol Biochem Behav 1990;35:485-7.
38. Cunningham CL. Localization of genes influencing ethanol-induced conditioned place preference and locomotor activity in BXD recombinant inbred mice. Psychopharmacology 1995;120:28-41.
39. Fidler TL, Bakner L, CunninghamCL. Conditioned place aversion induced by intragastric administration of ethanol in rats. Pharmacol Biochem Behav 2004;77:731-43.
40. Overton PG, Clark D. Burst firing in midbrain dopaminergic neurons. Brain Res Brain Res Rev 1997;25:312-34.
41. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 2004;24:53-62.
42. Johnson SW, Seutin V, North RA. Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump. Science 1992;258: 665-7.
43. Murase S, Grenhoff J, Chouvet G, Gonon FG, Svensson TH. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 1993;157:53-6.
44. Zheng F, Johnson SW. Group I metabotropic glutamate receptor-mediated enhancement of dopamine cell burst firing in rat ventral tegmental area in vitro. Brain Res 2002;948:171-4.
45. Taber MT, Das S, Fibiger HC. Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem 1995;65:1407-10.
46. Geisler S, Wise RA. Functional implications of glutamatergic projections to the ventral tegmental area. Rev Neurosci 2008;19:227-44.
47. Omelchenko N, Sesack SR. Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources. Neuroscience 2007;146:1259-74.
48. Sun N, Chi N, Lauzon N, Bishop S, Tan H, Laviolette SR. Acquisition, extinction, and recall of opiate rewardmemory are signaled by dynamic neuronal activity patterns in the prefrontal cortex. Cereb Cortex 2011;21:2665-80.
49. Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, et al. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci 2004;24:10707-15.
50. Cheer JF, Kendall DA, Mason R, Marsden CA. Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Neuropharmacology 2003;44: 633-41.
51. Childers SR. Activation of G-proteins in brain by endogenous and exogenous cannabinoids. AAPS J 2006;8:E112-7.
52. Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, et al. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 1999;289:1427-33.
53. Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G, et al. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berl) 2002;159:181-7.
54. Getachew B, Hauser SR, Dhaher R, Katner SN, Bell RL, Oster SM, et al. CB1 receptors regulate ethanol-seeking behavior and ethanol self-administration of ethanol-preferring (P) rats. Pharmacol Biochem Behav 2011;97:669-75.
55. Zarrindast MR, Ahmadi S, Haeri-Rohani A, Rezayof A, Jafari MR, Jafari-Sabet M. GABA(A) receptors in the basolateral amygdala are involved in mediating morphine reward. Brain Res 2004;1006:49-58.
56. Zarrindast MR, Fattahi Z, Rostami P, Rezayof A. Role of the cholinergic system in the rat basolateral amygdala on morphine-induced conditioned place preference. Pharmacol Biochem Behav 2005;82:1-10.
57. Gremel CM, Cunningham CL. Involvement of amygdala dopamine and nucleus accumbens NMDA receptors in ethanol-seeking behavior in mice. Neuropsychopharmacology 2009;34:1443-53.
58. Ford CP, Mark GP, Williams JT. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 2006;26:2788-97.
59. Rezayof A, Sardari M, Zarrindast MR, Nayer-Nouri T. Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference. Behav Brain Res 2011;220: 1-8.
60. Robinson TG, Beart PM. Excitant amino acid projections from rat amygdala and thalamus to nucleus accumbens. Brain Res Bull 1988;20:467-71.
61. Carlezon Jr WA, Thomas MJ. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 2009;56(Suppl. 1):122-32.
62. Floresco SB, Blaha CD, Yang CR, Phillips AG. Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons. J Neurosci 2001;21:6370-6.
63. Jones JL, Day JJ, Aragona BJ, Wheeler RA, Wightman RM, Carelli RM. Basolateral amygdala modulates terminal dopamine release in the nucleus accumbens and conditioned responding. Biol Psychiatry 2010;67:737-44.
64. Azad SC, Eder M, Marsicano G, Lutz B, Zieglgansberger W, Rammes G. Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem 2003;10: 116-28.
65. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 2001;21:9506-18.
66. Pistis M, Perra S, Pillolla G,Melis M, Gessa GL,Muntoni AL. Cannabinoidsmodulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 2004;46:115-25.
67. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998;83:393-411.
68. Rubino T, Guidali C, Vigano D, Realini N, Valenti M,Massi P, et al. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology 2008;54:151-60.
69. Svíženská I, Dubový P, Šulcová A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures- a short review. Pharmacol Biochem Behav 2008;90:501-11.
70. Richardson D, Ortori CA, Chapman V, Kendall DA, Barrett DA. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography- tandem electrospray ionization mass spectrometry. Anal Biochem 2007;360:216-26.
71. Panagis G, Vlachou S, Nomikos GG. Behavioral pharmacology of cannabinoidswith a focus on preclinical models for studying reinforcing and dependence-producing properties. Curr Drug Abuse Rev 2008;1:350-74.
72. Manzanedo C, Rodriguez-Arias M, Daza-Losada M, Maldonado C, Aguilar MA, Minarro J. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice. Behav Brain Funct 2010;6:19.
73. Howlett AC, Blume LC, Dalton GD. CB (1) cannabinoid receptors and their associated proteins. Curr Med Chem 2010;17:1382-93.
74. Smith TH, sim-Selley LI, Selley DE. Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? Br J Pharmacol 2010;60: 454-66.
75. Turkanis SA, Karler R. Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat. Psychopharmacology (Berl) 1981;75:294-8.
76. Margulies JE, Hammer RP. D9-tetrahydrocannabinol alter cerebral metabolism in a biphasic, dose-dependent manner in rat brain. Eur J Pharmacol 1991;202:373-8.
77. Tzavara ET,Wade M, Nomikos GG. Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. J Neurosci 2003;23: 9374-84.